BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1027 related articles for article (PubMed ID: 19008326)

  • 21. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Echocardiographic findings using tissue velocity imaging following passive containment surgery with the Acorn CorCap cardiac support device.
    Olsson A; Bredin F; Franco-Cereceda A
    Eur J Cardiothorac Surg; 2005 Sep; 28(3):448-53. PubMed ID: 16111611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
    Wong F; Siu S; Liu P; Blendis LM
    Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Left ventriculoplasty for non-ischemic cardiomyopathy with severe heart failure in 70 patients].
    Suma H; Isomura T; Horii T; Hisatomi K; Sato T; Kobashi T; Kanemitsu H; Hoshino J; Ueno H; Oda T
    J Cardiol; 2001 Jan; 37(1):1-10. PubMed ID: 11200650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial left ventriculectomy and mitral valve repair: favorable short-term results in carefully selected patients with advanced heart failure due to dilated cardiomyopathy.
    Wilhelm MJ; Hammel D; Schmid C; Kröner N; Stypmann J; Rothenburger M; Wenzelburger F; Schäfers M; Schmidt C; Baba HA; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2005 Nov; 24(11):1957-64. PubMed ID: 16297804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
    Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy.
    Alter P; Rupp H; Rominger MB; Vollrath A; Czerny F; Klose KJ; Maisch B
    Can J Physiol Pharmacol; 2007 Aug; 85(8):790-9. PubMed ID: 17901889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure.
    Volpe M; Tritto C; De Luca N; Mele AF; Lembo G; Rubattu S; Romano M; De Campora P; Enea I; Ricciardelli B
    J Clin Invest; 1991 Nov; 88(5):1481-9. PubMed ID: 1834698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy.
    Demachi J; Kagaya Y; Watanabe J; Sakuma M; Ikeda J; Kakuta Y; Motoyoshi I; Kohnosu T; Sakuma H; Shimazaki S; Sakai H; Kimpara T; Takahashi T; Omura K; Okada M; Saito H; Shirato K
    Neuromuscul Disord; 2004 Nov; 14(11):732-9. PubMed ID: 15482958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial hemodynamic and clinical effects of surgical ventricular restoration in patients with ischemic dilated cardiomyopathy.
    Tulner SA; Bax JJ; Bleeker GB; Steendijk P; Klautz RJ; Holman ER; Schalij MJ; Dion RA; van der Wall EE
    Ann Thorac Surg; 2006 Nov; 82(5):1721-7. PubMed ID: 17062236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamics at rest do not match clinical improvement after surgical ventricular restoration.
    Sartipy U; Albåge A; Insulander P; Lindblom D
    Scand Cardiovasc J; 2008 Dec; 42(6):405-10. PubMed ID: 18609047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.
    Walsh R; Boyer C; LaCorte J; Parnell V; Sison C; Chowdhury D; Ojamaa K
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):98-105. PubMed ID: 18179925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy.
    Suma H; Tanabe H; Uejima T; Isomura T; Horii T
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):280-4; discussion 284-5. PubMed ID: 19394851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
    J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year experience of the Batista operation for non-ischemic cardiomyopathy.
    Suma H; Isomura T; Horii T; Sato T; Kikuchi N; Iwahashi K; Hosokawa J
    J Cardiol; 1998 Oct; 32(4):269-76. PubMed ID: 9833234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nesiritide following maze and mitral valve surgery.
    Beaver TM; Winterstein A; Hess PJ; Martin TD; Arnaoutakis GJ; Peng YG; Ejaz AA
    J Card Surg; 2008; 23(5):431-6. PubMed ID: 18928481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.